Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Protective effects of BMP-7 against tumor necrosis factor α-induced oligodendrocyte apoptosis.
Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Molecular characterization of biotic and abiotic stress-responsive MAP kinase genes, IbMPK3 and IbMPK6, in sweetpotato.
Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Free-living Walking Behavior in Persons with Multiple Sclerosis at Increased and Normal Fall Risk: 838 Board #154 June 1, 2: 00 PM - 3: 30 PM.
Perturbed cholesterol homeostasis in aging spinal cord.
Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury.
Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.
Urbanization Theory for Growing Trend of Multiple Sclerosis Prevalence among Iranian Population.
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives.
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
Treatment of Orbital Complications Following Acute Rhinosinusitis in Children.
Women's experiences of menopause in an online MS cohort: A case series.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
Use of natalizumab in multiple sclerosis: current perspectives.
Consensus definitions for pediatric MS and other demyelinating disorders in childhood.
Substrate reduction therapy for Krabbe's disease.
Scattering the spotlight on microparticles.
Non-Gaussian Diffusion Imaging Shows Brain Myelin and Axonal Changes in Obstructive Sleep Apnea.
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.

Pages